WIB Exploring Themes in Translational Research: An Essential Element of Therapeutic Development-2017-08-09

Event Information
Event Name: 
WIB Exploring Themes in Translational Research: An Essential Element of Therapeutic Development
Event Date: 
08/09/2017 - 5:00pm
Event Location: 
Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA 94158
Event Details
Event Type: 
Panel Discussions
Event Details: 

WIB-San Francisco, Wednesday Evening, August 9, 2017

Topic: “Exploring Themes in Translational Research: An Essential Element of Therapeutic Development”
The panel includes our moderator, Maureen Cronin, Ph.D. (Executive Director of Informatics and Knowledge Utilization at Celgene), and panelists:
• Oranee Daniels, M.D. (CMO at Antiva Bioscience)
• Ellen Filvaroff, Ph.D. (Senior Director in Translational Development at Celgene)
• Nancy K. Pryer, Ph.D. (Vice President of Translational Sciences at BioMarin)
• Victoria Sung, Ph.D. (Director of Translational Development at Celgene)
Date and Time: Wednesday, August 9, 2017, 5:00 p.m. – 8:30 p.m. PST
Location: Nektar Therapeutics, 455 Mission Bay Boulevard South, San Francisco, CA 94158
Learn details and register at http://womeninbio.org/eventdetails.aspx?EventId=31688

Topic Description
WIB-San Francisco Bay Area will host a panel discussion at Nektar Therapeutics featuring women at the forefront of translational research. Transferring insights from bench to bedside is a critical component of the biopharmaceutical industry’s mission, and this event is focused on demystifying translational research in the context of a lively, interactive discussion. Our expert panelists will shed light on this underexplored process, drawing from their own experiences in therapeutic areas ranging from infectious disease to cancer to rare diseases.

These veteran researchers will share insights and describe the paths that led them to success in translational research. Please join us for what promises to be an exciting evening of discussion and networking!

Registration Deadline
August 7, 2017